Atlas Trials

An Open Study on the Preventive Effect of Early Mizoribine Conversion on BKV Nephropathy in Renal Transplant Recipients

Clinical trial NCT05293704 · UNKNOWN

Trial details

NCT number
NCT05293704
Sponsor
Lee's Pharmaceutical Limited
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Kidney Transplant RecipientsBK Virus
Start date
2022-05-01
Primary completion
2023-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.